BioLargo (BLGO) 11th Annual Waste and Environmental Symposium summary

Company overview and mission

• Focuses on environmental solutions for PFAS, water contamination, odor, VOCs, and infection control.

• Operates through four main divisions: engineering, R&D, medical (Clyra), and battery technology.

• Emphasizes sustainability, non-toxic solutions, and global accessibility.

• Maintains a pay-as-you-go growth model with minimal debt and strategic investments.

• Global operations with remote teams and international partnerships.

Financial performance and growth

• 2024 revenues reached $17.8 million, a 24% year-over-year increase.

• Revenue growth driven by Odor-No-More products and engineering services.

• Pooph pet odor product partnership expanded to over 40,000 stores, including Walmart and Amazon.

• $3 million in net cash and a market cap of $83 million.

• Investment in FDA-compliant manufacturing for medical products.

Technology highlights and innovation

• PFAS removal technology captures and destroys ultra-short and short chain PFAS using electrostatic membranes and electro-oxidization.

• Achieves up to 99.9% PFAS removal from leachate, outperforming competitors.

• Generates only 1-2 pounds of waste per 20,000-gallon/day system, compared to 20,000-40,000 pounds for traditional methods.

• First commercial PFAS installation underway in Lake Stockholm, New Jersey.

• Liquid sodium battery offers 2.9x lithium energy density, non-toxic, no rare earths, and strong performance in extreme temperatures.